SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-19-003804
Filing Date
2019-11-22
Accepted
2019-11-22 17:22:19
Documents
7
Period of Report
2019-12-12
Effectiveness Date
2019-11-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY phio_def14a.htm DEF 14A 130989
2 GRAPHIC logo.jpg GRAPHIC 2412
3 GRAPHIC image_005.jpg GRAPHIC 46903
4 GRAPHIC image_006.jpg GRAPHIC 32941
5 GRAPHIC image_007.jpg GRAPHIC 26566
6 GRAPHIC image_008.jpg GRAPHIC 35896
7 GRAPHIC signature.jpg GRAPHIC 2358
  Complete submission text file 0001683168-19-003804.txt   335482
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36304 | Film No.: 191242596
SIC: 2834 Pharmaceutical Preparations